Bumetanide and the blood‐brain barrier

E-ISSN： 2042-7158|67|4|501-510

ISSN： 0022-3573

Source： JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol.67, Iss.4, 2015-04, pp. : 501-510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood–brain barrier and neurological diseases

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 4, 2015-11 ,pp. : 351-361

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delivery of Chemically Modified Peptides and Proteins through the Blood-Brain Barrier

By Bickel Ulrich

CHIMIA International Journal for Chemistry, Vol. 49, Iss. 10, 1995-10 ,pp. : 386-395

Swiss Chemical Society

Access to resources Recommend Favorite

Blood–brain barrier: A novel therapeutic target in multiple sclerosis

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 2, 2015-05 ,pp. : 129-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of Intestinal Absorption and Blood-Brain Barrier Penetration by Computational Methods

Combinatorial Chemistry & High Throughput Screening, Vol. 4, Iss. 6, 2001-09 ,pp. : 477-496

Bentham Science Publishers

Access to resources Recommend Favorite

Scan‐stratified case‐control sampling for modeling blood–brain barrier integrity in multiple sclerosis

STATISTICS IN MEDICINE, Vol. 34, Iss. 20, 2015-09 ,pp. : 2872-2880

John Wiley & Sons Inc

Access to resources Recommend Favorite